Literature DB >> 7505485

Prevalence of markers of hepatitis viruses A, B, C and of HIV in healthy individuals and patients of a Cambodian province.

E G Thüring1, H I Joller-Jemelka, H Sareth, U Sokhan, C Reth, P Grob.   

Abstract

So far little was known on the epidemiology of hepatitis A, B, C and of AIDS in Cambodia and especially not in the rural area of Takeo. Therefore serological markers for past or ongoing infections with the disease causing viruses were measured in 559 healthy individuals (305 adults, 200 children and 54 mothers of children with liver disorders) and in 185 individuals (103 adults and 82 children) with liver or kidney diseases. In none of the 744 samples tested was anti-HIV detected. 10-37% of the children and 73% of the adults showed HBV-markers, HBsAg being detectable in 2-14% of the children and in 8% of the adults. The prevalence for anti-HCV was 6.5% in the adults with a predilection in males (9%). No markers for HCV infections were found in children. Growing, age related proportions of children (27-97%) and 100% of the adults were anti-HAV IgG positive. HBsAg was detected in 46% of the adults with acute hepatitis, in 45% of those with chronic hepatitis/liver cirrhosis and in 90% of patients with hepato-cellular carcinoma (HCC). In children the corresponding figures were 18% for acute hepatitis and 18% for chronic hepatitis. Patients with acute hepatitis or HCC had a similar prevalence of anti-HCV as healthy individuals. However, 34% of the adult patients with chronic hepatitis/cirrhosis showed signs of a HCV-infection. When the data were analysed with respect to modes of viral transmission, crowding, transmission by unsafe sexual practice or contaminated injection material, and to a lesser extent vertical transmission, seem to be relevant for HBV. The main mode of acquiring HCV infection is probably through medical injections of all sorts, a habit which is very popular in Takeo. Prophylactic measures should concentrate on the prevention of HBV and HCV infections by hygienic means. HBV mass vaccination should be considered in the future.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505485

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  12 in total

Review 1.  Hepatitis C in childhood.

Authors:  F Bortolotti
Journal:  Indian J Pediatr       Date:  1995 Sep-Oct       Impact factor: 1.967

2.  Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children.

Authors:  Y Meng Chhour; Gaye Ruble; Rathavuth Hong; Kyi Minn; Yuvatha Kdan; Touch Sok; Ananda Nisalak; Khin Saw Aye Myint; David W Vaughn; Timothy P Endy
Journal:  Emerg Infect Dis       Date:  2002-05       Impact factor: 6.883

3.  Prevalence of chronic hepatitis B virus infection after implementation of a hepatitis B vaccination program among children in three provinces in Cambodia.

Authors:  Bunsoth Mao; Minal K Patel; Karen Hennessey; Richard J W Duncan; Kathleen Wannemuehler; Sann Chan Soeung
Journal:  Vaccine       Date:  2013-05-15       Impact factor: 3.641

4.  Complete genomic sequence and phylogenetic relatedness of hepatitis B virus isolates in Cambodia.

Authors:  Tran Thien Tuan Huy; Amadou Alpha Sall; Jean Marc Reynes; Kenji Abe
Journal:  Virus Genes       Date:  2008-02-09       Impact factor: 2.332

5.  Prevalence of total hepatitis A antibody among 5 to 7 years old children and their mothers in Cambodia.

Authors:  Shintaro Nagashima; Ko Ko; Chikako Yamamoto; E Bunthen; Serge Ouoba; Channarena Chuon; Masayuki Ohisa; Aya Sugiyama; Tomoyuki Akita; Md Shafiqul Hossain; Vichit Ork; Bunsoth Mao; Junko Tanaka
Journal:  Sci Rep       Date:  2021-02-26       Impact factor: 4.379

6.  Rapid assessment of injection practices in Cambodia, 2002.

Authors:  Sirenda Vong; Joseph F Perz; Srun Sok; Seiharath Som; Susan Goldstein; Yvan Hutin; James Tulloch
Journal:  BMC Public Health       Date:  2005-06-02       Impact factor: 3.295

7.  Substitution of the CD81 Binding Site and β-Sandwich Area in E2 of HCV in Cambodia.

Authors:  Chikako Yamamoto; Shintaro Nagashima; Channarena Chuon; Ko Ko; Son Huy Do; Oline Lim; Sirany Hok; Somana Svay; Junko Matsuo; Keiko Katayama; Kazuaki Takahashi; Junko Tanaka
Journal:  Viruses       Date:  2020-05-16       Impact factor: 5.048

8.  Prevalence of and risk factors for hepatitis C virus antibody among people who inject drugs in Cambodia: a national biological and behavioral survey.

Authors:  Siyan Yi; Phalkun Mun; Pheak Chhoun; Navy Chann; Sovannary Tuot; Gitau Mburu
Journal:  Harm Reduct J       Date:  2019-04-29

Review 9.  Epidemiology of Viral Hepatitis and Liver Diseases in Cambodia.

Authors:  Bun Sreng; Hok Kimcheng; L Y Sovann; Eng Huot
Journal:  Euroasian J Hepatogastroenterol       Date:  2015-01-06

Review 10.  Viral Hepatitis in Cambodia: Past, Present, and Future.

Authors:  Bun Sreng; Chhith Sophal; Sok Srun; Chham Samnang; Eng Huot
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.